Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-10

FDA Approved: VUMERITY — Supplemental Application (Biogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for VUMERITY (diroximel fumarate) by Biogen Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VUMERITY (diroximel fumarate)

Snippet

SUPPL AP for VUMERITY (DIROXIMEL FUMARATE)